Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Mylan Laboratories Limited
FDA Inspection
•Mylan Laboratories Limited•May 13, 2019

Mylan Laboratories Limited – FDA Inspection, May 13, 2019

Record Details

This FDA Inspection record concerns Mylan Laboratories Limited, with an inspection on May 13, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Mylan Laboratories Limited
Inspection Date
May 13, 2019
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Dipesh K. Shah
  • Thomas J. Arista
View Company Profile

ID · 4cba956d-163a-43bd-9ccc-152e957b646f

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1089838
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

12
  1. 21 CFR 211.46(c)Air recirculation of dust from production areas
  2. 21 CFR 211.68(b)Backup data not assured as exact and complete
  3. 21 CFR 211.42(a)Buildings of Suitable Size, Construction, Location
  4. 21 CFR 211.100(b)Procedure Deviations Recorded and Justified
  5. 21 CFR 211.46(b)Equipment for Environmental Control
  6. 21 CFR 211.65(a)Equipment construction - reactive surfaces
  7. 21 CFR 211.63Equipment Design, Size and Location
  8. 21 CFR 211.113(b)Procedures for sterile drug products
  9. 21 CFR 211.42(c)(9)Control / Lab Operations Area
  10. 21 CFR 211.22(d)Procedures not in writing, fully followed

Showing 10 of 12 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Mylan Laboratories Limited

9
DateClassificationOfficeProject area
July 10, 2026Not classifiedOffice of Inspections and Investigations
February 24, 2023NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
January 16, 2023Not classifiedOffice of Inspections and Investigations
February 28, 2020VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
March 2, 2018VAIOffice of Inspections and InvestigationsGeneric Drug Evaluation
View all 9 other inspections on the company page
Other documents for Mylan Laboratories Limited
  • FDA Inspection 1329374 - 2026-07-10
  • FDA Inspection 1204816 - 2023-02-24
  • FDA Inspection 1196646 - 2023-01-16
  • FDA Inspection 1119165 - 2020-02-28
  • FDA Inspection 1042743 - 2018-03-02

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Mylan Laboratories Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.